Companies: 10,795·Total market cap: $144.5T
Radiopharm Theranostics Limited

Radiopharm Theranostics Limited

RADXNASDAQHealthcare● Active
$4.20
$-0.12(-2.78%)
Market Cap$5410440
P/E Ratio—
52W High$16.25
52W Low$3.62
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Radiopharm Theranostics Limited (RADX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001949257 · RADX · NASDAQ · as of Jun 8, 2026

Filing snapshot

124
Total Filings
6-K
Latest Form
2026-06-03
Most Recent
2024
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001949257 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-09-18
Fiscal Year End
Sep 18, 2025
Accession No.
0001213900-25-088699
Primary Document
ea0246510-20f_radio.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001949257 · Accession 0001213900-25-088699

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-03
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-03
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-06
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-06
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-01
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-30
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-23
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-20
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-16
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-08
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-07
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-01
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-01
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-31
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-31
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-27
View
Showing 1–15 of 124 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001949257  |  Exchange: NASDAQ · Healthcare

Radiopharm Theranostics Limited (NASDAQ: RADX) has submitted 124 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2024. As a Healthcare sector company with CIK 0001949257, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Radiopharm Theranostics Limited's most comprehensive regulatory disclosure. The most recent Radiopharm Theranostics Limited 10-K was filed on 2025-09-18 for fiscal year ending 2025. Historical RADX 10-K annual reports are available from 2022 through 2025.

Investors researching Radiopharm Theranostics Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
NBY SEC Filings →CYCN SEC Filings →BCLI SEC Filings →IBO SEC Filings →ADXN SEC Filings →TCRT SEC Filings →MTNB SEC Filings →KTTA SEC Filings →
→ RADX Financials→ RADX Earnings→ RADX Insider Trades

Frequently Asked Questions

RADX SEC Filings · 8 questions

Radiopharm Theranostics Limited (RADX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 124 filings and access original documents at no cost. Radiopharm Theranostics Limited's CIK is 0001949257.

RADX SEC filingsRadiopharm Theranostics Limited SEC documentsfind RADX 10-K